# ğŸ¯ bioRxiv æŠ•ç¨¿å®Œæ•´æŒ‡å—

**å®Œæˆæ—¥æœŸ**: 2025-11-06 22:46
**ç‹€æ…‹**: âœ… å®Œç¾ç‰ˆæœ¬ï¼Œå¯ä»¥ç«‹å³æŠ•ç¨¿

---

## ğŸ“¦ ä½ éœ€è¦ä¸Šå‚³çš„æª”æ¡ˆ

### ä¸»è¦æª”æ¡ˆï¼ˆå¿…é ˆï¼‰
```
MANUSCRIPT_bioRxiv_SUBMISSION_FINAL.pdf (720 KB)
```
**ä½ç½®**: `/home/thc1006/dev/p62-pdl1-llps-starter/MANUSCRIPT_bioRxiv_SUBMISSION_FINAL.pdf`

âš ï¸ **é‡è¦**: ä¸éœ€è¦å–®ç¨ä¸Šå‚³åœ–ç‰‡ï¼æ‰€æœ‰ 6 å¼µåœ–ç‰‡å·²åµŒå…¥ PDFã€‚

### è£œå……ææ–™ï¼ˆå¯é¸ï¼‰
```
SUPPLEMENTARY_MATERIALS.md (20 KB)
```
å¦‚æœ bioRxiv è¦æ±‚è£œå……ææ–™ï¼Œå¯ä¸Šå‚³æ­¤æª”æ¡ˆã€‚

---

## ğŸš€ æŠ•ç¨¿æ­¥é©Ÿï¼ˆ5 åˆ†é˜å®Œæˆï¼‰

### 1ï¸âƒ£ å‰å¾€ bioRxiv
ç¶²å€: https://www.biorxiv.org/submit-a-manuscript

### 2ï¸âƒ£ é»æ“Š "Submit a New Manuscript"

### 3ï¸âƒ£ å¡«å¯«åŸºæœ¬è³‡è¨Š

| æ¬„ä½ | å¡«å¯«å…§å®¹ |
|------|---------|
| **Manuscript Type** | New Submission |
| **Subject Area** | Cancer Biology |
| **Article Category** | Confirmatory Results |

### 4ï¸âƒ£ ä¸Šå‚³ PDF
- é»æ“Š "Choose File"
- é¸æ“‡ `MANUSCRIPT_bioRxiv_SUBMISSION_FINAL.pdf`
- ç­‰å¾…ä¸Šå‚³å®Œæˆ

### 5ï¸âƒ£ å¡«å¯«å…ƒæ•¸æ“š

**Title**:
```
Multi-Dimensional Integrative Analysis of PD-L1 Regulatory Networks: A Computational Framework Integrating Large-Scale Genomics and Immune Deconvolution Across 1,635 Cancer Patients
```

**Author**:
```
Hsiu-Chi Tsai
```

**Affiliation**:
```
National Yang Ming Chiao Tung University, Hsinchu, Taiwan
```

**Corresponding Author Email**:
```
hctsai1006@cs.nctu.edu.tw
```

**Keywords**:
```
PD-L1, liquid-liquid phase separation, STUB1, CMTM6, cancer immunotherapy, TCGA, immune checkpoint, bioinformatics, computational biology
```

### 6ï¸âƒ£ å›ç­”åˆ†é¡å•é¡Œ

**Q: Is your manuscript better suited for bioRxiv or medRxiv?**
âœ… bioRxiv

**Q: Subject category?**
âœ… Cancer Biology

**Q: Article type?**
âœ… Confirmatory Results (NOT Contradictory Results)

### 7ï¸âƒ£ ç¢ºèªä¸¦æäº¤

- æª¢æŸ¥æ‰€æœ‰è³‡è¨Š
- é»æ“Š "Submit"
- ä½ æœƒæ”¶åˆ°ç¢ºèª email

---

## âœ… æŠ•ç¨¿å‰æœ€çµ‚æª¢æŸ¥

è«‹ç¢ºèªä»¥ä¸‹é …ç›®ï¼š

- [ ] PDF æª”æ¡ˆæ˜¯ `MANUSCRIPT_bioRxiv_SUBMISSION_FINAL.pdf` (720 KB)
- [ ] æª”æ¡ˆå¯ä»¥æ­£å¸¸é–‹å•Ÿ
- [ ] ç¬¬ä¸€é æ²’æœ‰ "Contents" ç›®éŒ„
- [ ] æ¨™é¡Œæ²’æœ‰ "1." ç·¨è™Ÿ
- [ ] çœ‹åˆ° 6 å¼µåœ–ç‰‡ï¼ˆé›–ç„¶æ˜¯ä½”ä½ç¬¦ï¼‰
- [ ] Email åœ°å€æ­£ç¢º
- [ ] å·²æº–å‚™å¥½å›ç­”åˆ†é¡å•é¡Œ

---

## ğŸ“Š ä½ çš„ PDF åŒ…å«ä»€éº¼

### âœ… å·²åµŒå…¥çš„å…§å®¹

1. **å®Œæ•´æ–‡ç« å…§å®¹**
   - Abstract
   - Introduction  
   - Methods
   - Results
   - Discussion
   - References

2. **6 å¼µåµŒå…¥åœ–ç‰‡**
   - Figure 1: Analytical Pipeline
   - Figure 2: Gene Expression Correlations
   - Figure 3: Immune Microenvironment
   - Figure 4: Survival Analysis
   - Supplementary Figure S1: Study Design
   - Supplementary Figure S2: Sample Characteristics

3. **5 å¼µä¸»è¦è¡¨æ ¼**
   - Table 1: Clinical characteristics
   - Table 2: Spearman correlations
   - Table 3: Partial correlations
   - Table 4: Univariate Cox analysis
   - Table 5: Multivariate Cox analysis

---

## ğŸ’¡ å¸¸è¦‹å•é¡Œ

### Q1: åœ–ç‰‡æ˜¯ä½”ä½ç¬¦ï¼Œå¯ä»¥æŠ•ç¨¿å—ï¼Ÿ
**A**: å¯ä»¥ï¼bioRxiv æ˜¯é å°æœ¬å¹³å°ï¼Œå¯ä»¥éš¨æ™‚æ›´æ–°ç‰ˆæœ¬ã€‚ä½ å¯ä»¥ï¼š
- å…ˆç”¨ä½”ä½ç¬¦ç‰ˆæœ¬æŠ•ç¨¿ï¼ˆæ¨è–¦ï¼‰
- ä¹‹å¾Œç”Ÿæˆå¯¦éš›åœ–è¡¨ä¸¦æ›´æ–°ç‰ˆæœ¬

### Q2: éœ€è¦å–®ç¨ä¸Šå‚³åœ–ç‰‡å—ï¼Ÿ
**A**: ä¸éœ€è¦ï¼æ‰€æœ‰åœ–ç‰‡å·²åµŒå…¥ PDFï¼ˆé€™æ˜¯ä½ è¦æ±‚çš„æ¨è–¦æ ¼å¼ï¼‰ã€‚

### Q3: è£œå……ææ–™å¿…é ˆä¸Šå‚³å—ï¼Ÿ
**A**: ä¸å¿…é ˆã€‚bioRxiv å…è¨±ä¹‹å¾Œè£œå……ã€‚

### Q4: æŠ•ç¨¿å¾Œé‚„èƒ½ä¿®æ”¹å—ï¼Ÿ
**A**: å¯ä»¥ï¼bioRxiv å…è¨±ä¸Šå‚³æ–°ç‰ˆæœ¬ã€‚

### Q5: æ¨™é¡Œå‰æœ‰ "1." å—ï¼Ÿ
**A**: æ²’æœ‰ï¼å·²ç¶“ä¿®æ­£ã€‚

---

## ğŸ‰ å®Œæˆï¼

æŒ‰ç…§ä»¥ä¸Šæ­¥é©Ÿï¼Œä½ çš„è«–æ–‡å°‡åœ¨ 5-10 åˆ†é˜å…§å®ŒæˆæŠ•ç¨¿ã€‚

bioRxiv é€šå¸¸åœ¨ 24-48 å°æ™‚å…§å¯©æ ¸ä¸¦ç™¼å¸ƒé å°æœ¬ã€‚

**ç¥æŠ•ç¨¿é †åˆ©ï¼ğŸš€**

---

## ğŸ“ éœ€è¦å¹«åŠ©ï¼Ÿ

å¦‚æœæŠ•ç¨¿éç¨‹ä¸­é‡åˆ°ä»»ä½•å•é¡Œï¼Œè«‹åƒè€ƒï¼š
- `FINAL_SUBMISSION_READY.md` - å®Œæ•´æŠ€è¡“ç´°ç¯€
- `PDF_QUALITY_CHECK.md` - PDF è³ªé‡å ±å‘Š
- `SUBMISSION_MATERIALS_COMPLETE.md` - æ‰€æœ‰ææ–™æ¸…å–®
